Patent · US Active

Systems and methods for leadless pacing and shock therapy

US10265534B2 · kind B2 · utility

12Cited by
21References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 26, 2016
Grant dateApr 23, 2019
Priority date
Expiry dateOct 26, 2036

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N1/3987
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Techniques and systems for monitoring cardiac arrhythmias and delivering electrical stimulation therapy using a subcutaneous implantable cardioverter defibrillator (SICD) and a leadless pacing device (LPD) are described. For example, the SICD may detect a tachyarrhythmia within a first electrical signal from a heart and determine, based on the tachyarrhythmia, to deliver anti-tachyarrhythmia shock therapy to the patient to treat the detected arrhythmia. The LPD may receive communication from the SICD requesting the LPD deliver anti-tachycardia pacing to the heart and determine, based on a second electrical signal from the heart sensed by the LPD, whether to deliver anti-tachycardia pacing (ATP) to the heart. In this manner, the SICD and LPD may communicate to coordinate ATP and/or cardioversion/defibrillation therapy. In another example, the LPD may be configured to deliver post-shock pacing after detecting delivery of anti-tachyarrhythmia shock therapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.